-transparent.png){kind=logo}
To determine whether circulating immune complexes are present in the sera of patients with inflammatory bowel disease (IBD), a 125I-Clq binding assay was performed. Of the 55 IBD serum samples tested, the 24 ulcerative colitis samples demonstrated significant binding (33.1 +/- 8.3%, p = 0.02), whereas the 31 Crohn's samples bound essentially normal amounts (29.2 +/- 7.4%). A positive control group consisting of 27 patients with rheumatoid arthritis was also studied. Sera from 4 patients wiht IBD and colonic cancer when tested, bound 40.2 +/- 8.0% of the available 125I-Clq, while 10 patients with previous colectomies and ileostomies gave results similar to those of 15 healthy controls and 11 patients with irritable colon.
E Einstein, and
C Charland, and
W R Thayer
March 1982,
Journal of clinical microbiology,
E Einstein, and
C Charland, and
W R Thayer
June 1973,
Clinical and experimental immunology,
E Einstein, and
C Charland, and
W R Thayer
January 2015,
Experientia supplementum (2012),
E Einstein, and
C Charland, and
W R Thayer
January 1980,
Gastroenterologia Japonica,
E Einstein, and
C Charland, and
W R Thayer
March 1980,
Gut,
E Einstein, and
C Charland, and
W R Thayer
January 1989,
Terapevticheskii arkhiv,
E Einstein, and
C Charland, and
W R Thayer
June 1983,
Rinsho byori. The Japanese journal of clinical pathology,
E Einstein, and
C Charland, and
W R Thayer
January 1986,
International archives of allergy and applied immunology,
E Einstein, and
C Charland, and
W R Thayer
January 1980,
Gastroenterologia Japonica,
E Einstein, and
C Charland, and
W R Thayer
May 1979,
Nihon Jinzo Gakkai shi,
